Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 70 entries
Sorted by: Best Match Show Resources per page
Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: a systematic review and meta-analysis.

Journal of thoracic disease

Slooter MD, Eshuis WJ, Cuesta MA, Gisbertz SS, van Berge Henegouwen MI.
PMID: 31080655
J Thorac Dis. 2019 Apr;11:S755-S765. doi: 10.21037/jtd.2019.01.30.

BACKGROUND: Fluorescent imaging using indocyanine green (ICG) is an emerging technique that aids the surgeon with intraoperative decision making during upper gastrointestinal cancer surgery. In this systematic review we aim to provide an overview of current practice of fluorescence...

Cite
Slooter MD, Eshuis WJ, Cuesta MA, et al. Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: a systematic review and meta-analysis. J Thorac Dis. 2019;11:S755-S765doi: 10.21037/jtd.2019.01.30.
Slooter, M. D., Eshuis, W. J., Cuesta, M. A., Gisbertz, S. S., & van Berge Henegouwen, M. I. (2019). Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: a systematic review and meta-analysis. Journal of thoracic disease, 11S755-S765. https://doi.org/10.21037/jtd.2019.01.30
Slooter, Maxime D, et al. "Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: a systematic review and meta-analysis." Journal of thoracic disease vol. 11 (2019): S755-S765. doi: https://doi.org/10.21037/jtd.2019.01.30
Slooter MD, Eshuis WJ, Cuesta MA, Gisbertz SS, van Berge Henegouwen MI. Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: a systematic review and meta-analysis. J Thorac Dis. 2019 Apr;11:S755-S765. doi: 10.21037/jtd.2019.01.30. PMID: 31080655; PMCID: PMC6503266.
Copy Download .nbib Format: NLM
Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C, Diez Del Val I, Loureiro C, Parada-González P, Pintos-Martínez E, Vallejo FM, Achirica CM, Sánchez-Pernaute A, Campos AR, Bonavina L, Asti ELG, Poza AA, Gilsanz C, Nilsson M, Lindblad M, Gisbertz SS, van Berge Henegouwen MI, Romario UF, De Pascale S, Akhtar K, Bonjer HJ, Cuesta MA, van der Peet DL, Straatman J.
PMID: 34503850
Eur J Surg Oncol. 2021 Aug 30; doi: 10.1016/j.ejso.2021.08.031. Epub 2021 Aug 30.

INTRODUCTION: Minimally invasive techniques show improved short-term and comparable long-term outcomes compared to open techniques in the treatment of gastric cancer and improved survival has been seen with the implementation of multimodality treatment. Therefore, focus of research has shifted...

Cite
van der Wielen N, Daams F, Rosati R, et al. Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial. Eur J Surg Oncol. 2021;doi: 10.1016/j.ejso.2021.08.031.
van der Wielen, N., Daams, F., Rosati, R., Parise, P., Weitz, J., Reissfelder, C., Diez Del Val, I., Loureiro, C., Parada-González, P., Pintos-Martínez, E., Vallejo, F. M., Achirica, C. M., Sánchez-Pernaute, A., Campos, A. R., Bonavina, L., Asti, E. L. G., Poza, A. A., Gilsanz, C., Nilsson, M., Lindblad, M., Gisbertz, S. S., van Berge Henegouwen, M. I., Romario, U. F., De Pascale, S., Akhtar, K., Bonjer, H. J., Cuesta, M. A., van der Peet, D. L., & Straatman, J. (2021). Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, . https://doi.org/10.1016/j.ejso.2021.08.031
van der Wielen, Nicole, et al. "Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. (2021). doi: https://doi.org/10.1016/j.ejso.2021.08.031
van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C, Diez Del Val I, Loureiro C, Parada-González P, Pintos-Martínez E, Vallejo FM, Achirica CM, Sánchez-Pernaute A, Campos AR, Bonavina L, Asti ELG, Poza AA, Gilsanz C, Nilsson M, Lindblad M, Gisbertz SS, van Berge Henegouwen MI, Romario UF, De Pascale S, Akhtar K, Bonjer HJ, Cuesta MA, van der Peet DL, Straatman J. Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial. Eur J Surg Oncol. 2021 Aug 30; doi: 10.1016/j.ejso.2021.08.031. Epub 2021 Aug 30. PMID: 34503850.
Copy Download .nbib Format: NLM
Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types.

Clinical cancer research : an official journal of the American Association for Cancer Research

van der Wijngaart H, Hoes LR, van Berge Henegouwen JM, van der Velden DL, Zeverijn LJ, Roepman P, van Werkhoven E, de Leng WWJ, Jansen AML, Mehra N, Robbrecht DGJ, Labots M, de Groot DJA, Hoeben A, Hamberg P, Gelderblom H, Voest EE, Verheul HMW.
PMID: 34475104
Clin Cancer Res. 2021 Nov 15;27(22):6106-6114. doi: 10.1158/1078-0432.CCR-21-1104. Epub 2021 Sep 02.

PURPOSE: To assess the efficacy of olaparib, a PARP inhibitor (PARPi) in patients with tumors with PATIENTS AND METHODS: Patients with treatment-refractory RESULTS: Twenty-four evaluable patients with nine different tumor types harboring CONCLUSIONS: These data indicate that using PARPis...

Cite
van der Wijngaart H, Hoes LR, van Berge Henegouwen JM, et al. Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types. Clin Cancer Res. 2021;27(22):6106-6114doi: 10.1158/1078-0432.CCR-21-1104.
van der Wijngaart, H., Hoes, L. R., van Berge Henegouwen, J. M., van der Velden, D. L., Zeverijn, L. J., Roepman, P., van Werkhoven, E., de Leng, W. W. J., Jansen, A. M. L., Mehra, N., Robbrecht, D. G. J., Labots, M., de Groot, D. J. A., Hoeben, A., Hamberg, P., Gelderblom, H., Voest, E. E., & Verheul, H. M. W. (2021). Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(22), 6106-6114. https://doi.org/10.1158/1078-0432.CCR-21-1104
van der Wijngaart, Hanneke, et al. "Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,22 (2021): 6106-6114. doi: https://doi.org/10.1158/1078-0432.CCR-21-1104
van der Wijngaart H, Hoes LR, van Berge Henegouwen JM, van der Velden DL, Zeverijn LJ, Roepman P, van Werkhoven E, de Leng WWJ, Jansen AML, Mehra N, Robbrecht DGJ, Labots M, de Groot DJA, Hoeben A, Hamberg P, Gelderblom H, Voest EE, Verheul HMW. Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types. Clin Cancer Res. 2021 Nov 15;27(22):6106-6114. doi: 10.1158/1078-0432.CCR-21-1104. Epub 2021 Sep 02. PMID: 34475104.
Copy Download .nbib Format: NLM
Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Hagens E, Tukanova K, Jamel S, van Berge Henegouwen M, Hanna GB, Gisbertz S, Markar SR.
PMID: 33893494
Dis Esophagus. 2021 Apr 24; doi: 10.1093/dote/doab021. Epub 2021 Apr 24.

INTRODUCTION: The prognostic value of histomorphologic regression in primary esophageal cancer has been previously established, however the impact of lymph node (LN) response on survival still remains unclear. The aim of this review was to assess the prognostic significance...

Cite
Hagens E, Tukanova K, Jamel S, et al. Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2021;doi: 10.1093/dote/doab021.
Hagens, E., Tukanova, K., Jamel, S., van Berge Henegouwen, M., Hanna, G. B., Gisbertz, S., & Markar, S. R. (2021). Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, . https://doi.org/10.1093/dote/doab021
Hagens, Eliza, et al. "Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis." Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus vol. (2021). doi: https://doi.org/10.1093/dote/doab021
Hagens E, Tukanova K, Jamel S, van Berge Henegouwen M, Hanna GB, Gisbertz S, Markar SR. Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus. 2021 Apr 24; doi: 10.1093/dote/doab021. Epub 2021 Apr 24. PMID: 33893494.
Copy Download .nbib Format: NLM
Gastrectomy Versus Esophagectomy For Gastroesophageal Junction Tumors: Short- And Long-term Outcomes From the Dutch Upper GI Cancer Audit.

Annals of surgery

Jezerskyte E, Mertens AC, van Dieren S, Eshuis WJ, Sprangers MAG, van Berge Henegouwen MI, Gisbertz SS.
PMID: 33214453
Ann Surg. 2020 Nov 17; doi: 10.1097/SLA.0000000000004610. Epub 2020 Nov 17.

OBJECTIVE: Investigate long-term survival, morbidity, mortality and pathology results in patients following esophagectomy or total gastrectomy for GEJ cancer.BACKGROUND: Both a total gastrectomy and an esophagectomy may be valid treatment options in patients with gastroesophageal junction (GEJ) cancer. Which...

Cite
Jezerskyte E, Mertens AC, van Dieren S, et al. Gastrectomy Versus Esophagectomy For Gastroesophageal Junction Tumors: Short- And Long-term Outcomes From the Dutch Upper GI Cancer Audit. Ann Surg. 2020;doi: 10.1097/SLA.0000000000004610.
Jezerskyte, E., Mertens, A. C., van Dieren, S., Eshuis, W. J., Sprangers, M. A. G., van Berge Henegouwen, M. I., Gisbertz, S. S. (2020). Gastrectomy Versus Esophagectomy For Gastroesophageal Junction Tumors: Short- And Long-term Outcomes From the Dutch Upper GI Cancer Audit. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000004610
Jezerskyte, Egle, et al. "Gastrectomy Versus Esophagectomy For Gastroesophageal Junction Tumors: Short- And Long-term Outcomes From the Dutch Upper GI Cancer Audit." Annals of surgery vol. (2020). doi: https://doi.org/10.1097/SLA.0000000000004610
Jezerskyte E, Mertens AC, van Dieren S, Eshuis WJ, Sprangers MAG, van Berge Henegouwen MI, Gisbertz SS. Gastrectomy Versus Esophagectomy For Gastroesophageal Junction Tumors: Short- And Long-term Outcomes From the Dutch Upper GI Cancer Audit. Ann Surg. 2020 Nov 17; doi: 10.1097/SLA.0000000000004610. Epub 2020 Nov 17. PMID: 33214453.
Copy Download .nbib Format: NLM
Gastro-esophageal junction cancers: what is the best minimally invasive approach?.

Journal of thoracic disease

Jezerskyte E, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS.
PMID: 28815071
J Thorac Dis. 2017 Jul;9:S751-S760. doi: 10.21037/jtd.2017.06.56.

The short-term advantages of minimally invasive esophagectomy (MIE) in terms of less morbidity and better quality of life (QoL) in comparison with open esophagectomy (OE) became visible in the last few years. There are two main MIE approaches: a...

Cite
Jezerskyte E, van Berge Henegouwen MI, Cuesta MA, et al. Gastro-esophageal junction cancers: what is the best minimally invasive approach?. J Thorac Dis. 2017;9:S751-S760doi: 10.21037/jtd.2017.06.56.
Jezerskyte, E., van Berge Henegouwen, M. I., Cuesta, M. A., & Gisbertz, S. S. (2017). Gastro-esophageal junction cancers: what is the best minimally invasive approach?. Journal of thoracic disease, 9S751-S760. https://doi.org/10.21037/jtd.2017.06.56
Jezerskyte, Egle, et al. "Gastro-esophageal junction cancers: what is the best minimally invasive approach?." Journal of thoracic disease vol. 9 (2017): S751-S760. doi: https://doi.org/10.21037/jtd.2017.06.56
Jezerskyte E, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. Gastro-esophageal junction cancers: what is the best minimally invasive approach?. J Thorac Dis. 2017 Jul;9:S751-S760. doi: 10.21037/jtd.2017.06.56. PMID: 28815071; PMCID: PMC5538974.
Copy Download .nbib Format: NLM
Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis.

Cancers

van den Ende T, Ter Veer E, Mali RMA, van Berge Henegouwen MI, Hulshof MCCM, van Oijen MGH, van Laarhoven HWM.
PMID: 31013858
Cancers (Basel). 2019 Apr 12;11(4). doi: 10.3390/cancers11040530.

BACKGROUND: An overview of promising prognostic variables and predictive subgroups concerning the curative treatment of esophageal and gastric cancer from randomized controlled trials (RCTs) is lacking. Therefore, we conducted a systematic review and meta-analysis.METHODS: PubMed, EMBASE, CENTRAL, and ASCO/ESMO...

Cite
van den Ende T, Ter Veer E, Mali RMA, et al. Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis. Cancers (Basel). 2019;11(4)doi: 10.3390/cancers11040530.
van den Ende, T., Ter Veer, E., Mali, R. M. A., van Berge Henegouwen, M. I., Hulshof, M. C. C. M., van Oijen, M. G. H., & van Laarhoven, H. W. M. (2019). Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis. Cancers, 11(4), . https://doi.org/10.3390/cancers11040530
van den Ende, Tom, et al. "Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis." Cancers vol. 11,4 (2019). doi: https://doi.org/10.3390/cancers11040530
van den Ende T, Ter Veer E, Mali RMA, van Berge Henegouwen MI, Hulshof MCCM, van Oijen MGH, van Laarhoven HWM. Prognostic and Predictive Factors for the Curative Treatment of Esophageal and Gastric Cancer in Randomized Controlled Trials: A Systematic Review and Meta-Analysis. Cancers (Basel). 2019 Apr 12;11(4). doi: 10.3390/cancers11040530. PMID: 31013858; PMCID: PMC6521055.
Copy Download .nbib Format: NLM
Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green.

Surgical endoscopy

Overwater A, Weusten BLAM, Ruurda JP, van Hillegersberg R, Bennink RJ, de Keizer B, Meijer SL, Brosens LAA, Pouw RE, Bergman JJGHM, van Berge Henegouwen MI, Gisbertz SS.
PMID: 34046715
Surg Endosc. 2021 May 27; doi: 10.1007/s00464-021-08551-6. Epub 2021 May 27.

BACKGROUND: Minimally invasive esophagectomy with two-field lymphadenectomy is standard of care for T1b esophageal adenocarcinoma (EAC) with a high risk of lymph node metastasis. Sentinel node navigation surgery (SNNS) is a well-known concept to tailor the extent of lymphadenectomy....

Cite
Overwater A, Weusten BLAM, Ruurda JP, et al. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green. Surg Endosc. 2021;doi: 10.1007/s00464-021-08551-6.
Overwater, A., Weusten, B. L. A. M., Ruurda, J. P., van Hillegersberg, R., Bennink, R. J., de Keizer, B., Meijer, S. L., Brosens, L. A. A., Pouw, R. E., Bergman, J. J. G. H. M., van Berge Henegouwen, M. I., & Gisbertz, S. S. (2021). Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green. Surgical endoscopy, . https://doi.org/10.1007/s00464-021-08551-6
Overwater, Anouk, et al. "Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green." Surgical endoscopy vol. (2021). doi: https://doi.org/10.1007/s00464-021-08551-6
Overwater A, Weusten BLAM, Ruurda JP, van Hillegersberg R, Bennink RJ, de Keizer B, Meijer SL, Brosens LAA, Pouw RE, Bergman JJGHM, van Berge Henegouwen MI, Gisbertz SS. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green. Surg Endosc. 2021 May 27; doi: 10.1007/s00464-021-08551-6. Epub 2021 May 27. PMID: 34046715.
Copy Download .nbib Format: NLM
Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study.

Cancers

Besseling J, Reitsma J, Van Erkelens JA, Schepens MHJ, Siroen MPC, Ziedses des Plantes CMP, van Berge Henegouwen MI, Beerepoot LV, Van Voorthuizen T, Van Zuylen L, Verhoeven RHA, van Laarhoven H.
PMID: 33466279
Cancers (Basel). 2021 Jan 05;13(1). doi: 10.3390/cancers13010145.

Since intensive care unit (ICU) admission and chemotherapy use near death impair the quality of life, we studied the prevalence of both and their correlation with hospital volume in incurable gastroesophageal cancer patients as both impair the quality of...

Cite
Besseling J, Reitsma J, Van Erkelens JA, et al. Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study. Cancers (Basel). 2021;13(1)doi: 10.3390/cancers13010145.
Besseling, J., Reitsma, J., Van Erkelens, J. A., Schepens, M. H. J., Siroen, M. P. C., Ziedses des Plantes, C. M. P., van Berge Henegouwen, M. I., Beerepoot, L. V., Van Voorthuizen, T., Van Zuylen, L., Verhoeven, R. H. A., & van Laarhoven, H. (2021). Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study. Cancers, 13(1), . https://doi.org/10.3390/cancers13010145
Besseling, Joost, et al. "Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study." Cancers vol. 13,1 (2021). doi: https://doi.org/10.3390/cancers13010145
Besseling J, Reitsma J, Van Erkelens JA, Schepens MHJ, Siroen MPC, Ziedses des Plantes CMP, van Berge Henegouwen MI, Beerepoot LV, Van Voorthuizen T, Van Zuylen L, Verhoeven RHA, van Laarhoven H. Use of Palliative Chemotherapy and ICU Admissions in Gastric and Esophageal Cancer Patients in the Last Phase of Life: A Nationwide Observational Study. Cancers (Basel). 2021 Jan 05;13(1). doi: 10.3390/cancers13010145. PMID: 33466279; PMCID: PMC7794997.
Copy Download .nbib Format: NLM
Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study.

Annals of surgery

Claassen L, Hannink G, Luyer MDP, Ainsworth AP, van Berge Henegouwen MI, Cheong E, Daams F, van Det MJ, van Duijvendijk P, Gisbertz SS, Gutschow CA, Heisterkamp J, Kauppi JT, Klarenbeek BR, Kouwenhoven EA, Langenhoff BS, Larsen MH, Martijnse IS, van Nieuwenhoven EJ, van der Peet DL, Pierie JEN, Pierik REGJM, Polat F, Räsänen JV, Rouvelas I, Sosef MN, Wassenaar EB, van den Wildenberg FJH, van der Zaag ES, Nilsson M, Nieuwenhuijzen GAP, van Workum F, Rosman C.
PMID: 33605581
Ann Surg. 2021 Feb 10; doi: 10.1097/SLA.0000000000004801. Epub 2021 Feb 10.

OBJECTIVE: To describe the pooled learning curves of Ivor Lewis TMIE in hospitals stratified by predefined hospital and surgeon related factors.SUMMARY BACKGROUND DATA: Ivor Lewis totally minimally invasive esophagectomy (TMIE) is known to have a long learning curve which...

Cite
Claassen L, Hannink G, Luyer MDP, et al. Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study. Ann Surg. 2021;doi: 10.1097/SLA.0000000000004801.
Claassen, L., Hannink, G., Luyer, M. D. P., Ainsworth, A. P., van Berge Henegouwen, M. I., Cheong, E., Daams, F., van Det, M. J., van Duijvendijk, P., Gisbertz, S. S., Gutschow, C. A., Heisterkamp, J., Kauppi, J. T., Klarenbeek, B. R., Kouwenhoven, E. A., Langenhoff, B. S., Larsen, M. H., Martijnse, I. S., van Nieuwenhoven, E. J., van der Peet, D. L., Pierie, J. E. N., Pierik, R. E. G. J. M., Polat, F., Räsänen, J. V., Rouvelas, I., Sosef, M. N., Wassenaar, E. B., van den Wildenberg, F. J. H., van der Zaag, E. S., Nilsson, M., Nieuwenhuijzen, G. A. P., van Workum, F., Rosman, C. (2021). Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000004801
Claassen, Linda, et al. "Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study." Annals of surgery vol. (2021). doi: https://doi.org/10.1097/SLA.0000000000004801
Claassen L, Hannink G, Luyer MDP, Ainsworth AP, van Berge Henegouwen MI, Cheong E, Daams F, van Det MJ, van Duijvendijk P, Gisbertz SS, Gutschow CA, Heisterkamp J, Kauppi JT, Klarenbeek BR, Kouwenhoven EA, Langenhoff BS, Larsen MH, Martijnse IS, van Nieuwenhoven EJ, van der Peet DL, Pierie JEN, Pierik REGJM, Polat F, Räsänen JV, Rouvelas I, Sosef MN, Wassenaar EB, van den Wildenberg FJH, van der Zaag ES, Nilsson M, Nieuwenhuijzen GAP, van Workum F, Rosman C. Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multi-National Cohort Study. Ann Surg. 2021 Feb 10; doi: 10.1097/SLA.0000000000004801. Epub 2021 Feb 10. PMID: 33605581.
Copy Download .nbib Format: NLM
Patient-reported outcomes after oesophagectomy in the multicentre LASER study.

The British journal of surgery

Markar SR, Sounderajah V, Johar A, Zaninotto G, Castoro C, Lagergren P, Elliott JA, Gisbertz SS, Mariette C, Alfieri R, Huddy J, Pinto E, Scarpa M, Klevebro F, Sunde B, Murphy CF, Greene C, Ravi N, Piessen G, Brenkman H, Ruurda J, van Hillegersberg R, Lagarde SM, Wijnhoven BP, Pera M, Roigg J, Castro S, Matthijsen R, Findlay J, Antonowicz S, Maynard N, McCormack O, Ariyarathenam A, Sanders G, Cheong E, Jaunoo S, Allum W, van Lanschot J, Nilsson M, Reynolds JV, van Berge Henegouwen MI, Hanna GB.
PMID: 33975337
Br J Surg. 2021 Sep 27;108(9):1090-1096. doi: 10.1093/bjs/znab124.

BACKGROUND: Data on the long-term symptom burden in patients surviving oesophageal cancer surgery are scarce. The aim of this study was to identify the most prevalent symptoms and their interactions with health-related quality of life.METHODS: This was a cross-sectional...

Cite
Markar SR, Sounderajah V, Johar A, et al. Patient-reported outcomes after oesophagectomy in the multicentre LASER study. Br J Surg. 2021;108(9):1090-1096doi: 10.1093/bjs/znab124.
Markar, S. R., Sounderajah, V., Johar, A., Zaninotto, G., Castoro, C., Lagergren, P., Elliott, J. A., Gisbertz, S. S., Mariette, C., Alfieri, R., Huddy, J., Pinto, E., Scarpa, M., Klevebro, F., Sunde, B., Murphy, C. F., Greene, C., Ravi, N., Piessen, G., Brenkman, H., Ruurda, J., van Hillegersberg, R., Lagarde, S. M., Wijnhoven, B. P., Pera, M., Roigg, J., Castro, S., Matthijsen, R., Findlay, J., Antonowicz, S., Maynard, N., McCormack, O., Ariyarathenam, A., Sanders, G., Cheong, E., Jaunoo, S., Allum, W., van Lanschot, J., Nilsson, M., Reynolds, J. V., van Berge Henegouwen, M. I., & Hanna, G. B. (2021). Patient-reported outcomes after oesophagectomy in the multicentre LASER study. The British journal of surgery, 108(9), 1090-1096. https://doi.org/10.1093/bjs/znab124
Markar, S R, et al. "Patient-reported outcomes after oesophagectomy in the multicentre LASER study." The British journal of surgery vol. 108,9 (2021): 1090-1096. doi: https://doi.org/10.1093/bjs/znab124
Markar SR, Sounderajah V, Johar A, Zaninotto G, Castoro C, Lagergren P, Elliott JA, Gisbertz SS, Mariette C, Alfieri R, Huddy J, Pinto E, Scarpa M, Klevebro F, Sunde B, Murphy CF, Greene C, Ravi N, Piessen G, Brenkman H, Ruurda J, van Hillegersberg R, Lagarde SM, Wijnhoven BP, Pera M, Roigg J, Castro S, Matthijsen R, Findlay J, Antonowicz S, Maynard N, McCormack O, Ariyarathenam A, Sanders G, Cheong E, Jaunoo S, Allum W, van Lanschot J, Nilsson M, Reynolds JV, van Berge Henegouwen MI, Hanna GB. Patient-reported outcomes after oesophagectomy in the multicentre LASER study. Br J Surg. 2021 Sep 27;108(9):1090-1096. doi: 10.1093/bjs/znab124. PMID: 33975337.
Copy Download .nbib Format: NLM
Randomised trial, Minimally Invasive Oesophagectomy versus open oesophagectomy for patients with resectable oesophageal cancer.

Journal of thoracic disease

Cuesta MA, Biere SS, van Berge Henegouwen MI, van der Peet DL.
PMID: 23050108
J Thorac Dis. 2012 Oct;4(5):462-4. doi: 10.3978/j.issn.2072-1439.2012.08.12.

No abstract available.

Cite
Cuesta MA, Biere SS, van Berge Henegouwen MI, et al. Randomised trial, Minimally Invasive Oesophagectomy versus open oesophagectomy for patients with resectable oesophageal cancer. J Thorac Dis. 2012;4(5):462-4doi: 10.3978/j.issn.2072-1439.2012.08.12.
Cuesta, M. A., Biere, S. S., van Berge Henegouwen, M. I., & van der Peet, D. L. (2012). Randomised trial, Minimally Invasive Oesophagectomy versus open oesophagectomy for patients with resectable oesophageal cancer. Journal of thoracic disease, 4(5), 462-4. https://doi.org/10.3978/j.issn.2072-1439.2012.08.12
Cuesta, Miguel A, et al. "Randomised trial, Minimally Invasive Oesophagectomy versus open oesophagectomy for patients with resectable oesophageal cancer." Journal of thoracic disease vol. 4,5 (2012): 462-4. doi: https://doi.org/10.3978/j.issn.2072-1439.2012.08.12
Cuesta MA, Biere SS, van Berge Henegouwen MI, van der Peet DL. Randomised trial, Minimally Invasive Oesophagectomy versus open oesophagectomy for patients with resectable oesophageal cancer. J Thorac Dis. 2012 Oct;4(5):462-4. doi: 10.3978/j.issn.2072-1439.2012.08.12. PMID: 23050108; PMCID: PMC3461077.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 70 entries